Design Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Design Therapeutics Capital Expenditures (CapEx) Growth & History (DSGN)
Design Therapeutics's capital expenditures (capex) was $193,000 for fiscal 2025.
View full Design Therapeutics company overviewDesign Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $193,000 | −$147,000 | −43.24% |
| 2024 | 2024-12-31 | $340,000 | $84,000 | +32.81% |
| 2023 | 2023-12-31 | $256,000 | −$662,000 | −72.11% |
| 2022 | 2022-12-31 | $918,000 | −$620,000 | −40.31% |
| 2021 | 2021-12-31 | $1.5M | $1.5M | +1923.68% |
| 2020 | 2020-12-31 | $76,000 | — | — |
Design Therapeutics quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21,000 | −$66,000 | −75.86% |
| Q1 2026 | 2026-03-31 | $0 | −$72,000 | — |
| Q4 2025 | 2025-12-31 | $34,000 | $34,000 | — |
| Q3 2025 | 2025-09-30 | $0 | −$16,000 | — |
| Q2 2025 | 2025-06-30 | $87,000 | −$74,000 | −45.96% |
| Q1 2025 | 2025-03-31 | $72,000 | −$123,000 | −63.08% |
| Q4 2024 | 2024-12-31 | $0 | −$27,000 | — |
| Q3 2024 | 2024-09-30 | $16,000 | −$37,000 | −69.81% |
| Q2 2024 | 2024-06-30 | $161,000 | $72,000 | +80.90% |
| Q1 2024 | 2024-03-31 | $195,000 | $108,000 | +124.14% |
| Q4 2023 | 2023-12-31 | $27,000 | −$261,000 | −90.63% |
| Q3 2023 | 2023-09-30 | $53,000 | −$257,000 | −82.90% |
| Q2 2023 | 2023-06-30 | $89,000 | −$155,000 | −63.52% |
| Q1 2023 | 2023-03-31 | $87,000 | $11,000 | +14.47% |
| Q4 2022 | 2022-12-31 | $288,000 | −$66,000 | −18.64% |
| Q3 2022 | 2022-09-30 | $310,000 | −$658,000 | −67.98% |
| Q2 2022 | 2022-06-30 | $244,000 | $61,000 | +33.33% |
| Q1 2022 | 2022-03-31 | $76,000 | $43,000 | +130.30% |
| Q4 2021 | 2021-12-31 | $354,000 | — | — |
| Q3 2021 | 2021-09-30 | $968,000 | — | — |
| Q2 2021 | 2021-06-30 | $183,000 | — | — |
| Q1 2021 | 2021-03-31 | $33,000 | — | — |
Design Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Design Therapeutics's capital expenditures (capex) increased from $76,000 to $193,000, a change of $117,000. The latest reported quarter, Q2 2026, shows $21,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Design Therapeutics source filings ↗